Ñï×Ó½­Ò©Òµ¼¯ÍŹÌÌåÖÆ¼ÁQCС×é×î½üÒª¹¥¿ËµÄÒ»¸öÄѹأ¬£¬£¬£¬£¬£¬£¬£¬ÈÃС×é³ÉÔ±Éî¿ÌÒâ»áµ½Á˼á³ÖµÄÒâÒå¡£¡£¡£¡£¡£¡£¡£°ÙÀÖÃß½ºÄÒ×÷Ϊ¹ÌÌåÖÆ¼Á3ºÅ³µ¼äµÄÍõÅÆÆ·ÖÖ£¬£¬£¬£¬£¬£¬£¬£¬ÔÚÒ©Æ·°ü×°Àú³ÌÖÐÎÞÒâ±£´æ·â¿Ú²»ÑŹ۵ÄȱÏÝ£¬£¬£¬£¬£¬£¬£¬£¬¹ÌÌåÖÆ¼ÁQCС×é¾öÒéÒªÄÃÏÂÕâÒ»ÄÑÌ⣬£¬£¬£¬£¬£¬£¬£¬½«¿ÎÌâÃüÃûΪ“½µµÍ°ÙÀÖÃß½ºÄÒÂÁ²­·â¿Ú»ú·â¿ÚȱÏÝÂÊ”¡£¡£¡£¡£¡£¡£¡£

    ¿ÎÌâÈ·¶¨Ö®ºó£¬£¬£¬£¬£¬£¬£¬£¬ÎªÁËÕÒ³öÎÊÌâµÄ»ù´¡Ôµ¹ÊÔ­ÓÉ£¬£¬£¬£¬£¬£¬£¬£¬³µ¼ä´ÓÈË¡¢»ú¡¢ÁÏ¡¢·¨¡¢»·Îå¸ö·½ÃæÖð¸öÆÊÎöÈ·ÈÏ¡£¡£¡£¡£¡£¡£¡£QCС×é¾­ÓÉÈÏÕæµØÌÖÂÛ£¬£¬£¬£¬£¬£¬£¬£¬×îÖÕ¾öÒé¶ÔÂÁ²­·â¿Ú»ú¾ÙÐм¼¸Ä¡£¡£¡£¡£¡£¡£¡£ÕâÏîʹÃü¾ÍÂäÔÚ×°±¸¼¼¸ÄµÄÖ÷ҪʵÑéÈËÁõ°ÂÉíÉÏ¡£¡£¡£¡£¡£¡£¡£½Óµ½ÕâһʹÃü£¬£¬£¬£¬£¬£¬£¬£¬Áõ°Â°ë¿ªÍçЦµØËµ£º“µÃ£¬£¬£¬£¬£¬£¬£¬£¬½üÆÚÎÒÒª¸úÕą̂װ±¸²»Àë²»ÆúÁË¡£¡£¡£¡£¡£¡£¡£”

    ÔÚÁõ°ÂºÍ³µ¼äµÄ×°±¸Ö÷¸ÉÃǼӰà¼ÓµãÑо¿µÄͬʱ£¬£¬£¬£¬£¬£¬£¬£¬Ò»³¡Í·ÄԷ籩ҲÔÚÖ÷Òª¾ÙÐС£¡£¡£¡£¡£¡£¡£“°ÙÀÖÃß½ºÄÒÔÚ·â¿Úʱ£¬£¬£¬£¬£¬£¬£¬£¬ÈôÊÇÂÁ²­·ºÆð·´ÖÃÕ÷Ï󣬣¬£¬£¬£¬£¬£¬£¬¾Í»áÓ°ÏìÆ¿×ӵķâ¿Ú£¬£¬£¬£¬£¬£¬£¬£¬¶ø¿¨¿¨Íå88×°±¸ÎÞ·¨Ê¶±ð²¢ÊµÊ±ÌÞ³ý¡£¡£¡£¡£¡£¡£¡£”С×é³ÉÔ±ÎâÖ¾ÕÂÊ×ÏÈÌá³öÎÊÌâ¡£¡£¡£¡£¡£¡£¡£“¿ÉÒÔ×öÒ»¸ö×°±¸¼¼¸Ä£¬£¬£¬£¬£¬£¬£¬£¬ÔöÌíÒ»¸öÉ«±ê´«¸ÐÆ÷¡£¡£¡£¡£¡£¡£¡£”¿ÎÌâ×éÈÏÕæÈËÁõ±þ˳Ìá³ö¼Æ»®¡£¡£¡£¡£¡£¡£¡£Ð¡×é³ÉÔ±¾­ÓÉ×ÐϸÌÖÂÛ£¬£¬£¬£¬£¬£¬£¬£¬Ò»ÖÂÒÔΪ´Ë¼Æ»®¿ÉÐС£¡£¡£¡£¡£¡£¡£ËæºóС×é³ÉÔ±×îÏȶÔÖÖÖÖ´«¸ÐÆ÷¾ÙÐе÷ÑУ¬£¬£¬£¬£¬£¬£¬£¬Í¨¹ý¶Ôʶ±ðÂÊ¡¢³ß´ç¼°¼ÛÇ®µÈ·½Ãæ×ÛºÏ˼Á¿£¬£¬£¬£¬£¬£¬£¬£¬Ñ¡³öÁË×îÊʺϳµ¼ä×°±¸Ê¹ÓõÄÉ«±ê´«¸ÐÆ÷£¬£¬£¬£¬£¬£¬£¬£¬³µ¼äÔÚÍê³ÉÉ«±ê´«¸ÐÆ÷µÄ×°Öõ÷ÊԺ󣬣¬£¬£¬£¬£¬£¬£¬Í¨¹ýÒ»Ö±ÊÔÑ飬£¬£¬£¬£¬£¬£¬£¬×îÖÕ´«¸ÐÆ÷ʶ±ðÌÞ³ýÂʵִï100%¡£¡£¡£¡£¡£¡£¡£

    ÔÚÁ¢ÒìÖÐÒ»Ö±·¢Ã÷ÐÂÎÊÌ⣬£¬£¬£¬£¬£¬£¬£¬ÓÖһֱˢУ¬£¬£¬£¬£¬£¬£¬£¬Õâ¾ÍÊÇËùνµÄ×ÖÕå¾ä×ᣡ£¡£¡£¡£¡£¡£ÔÚÑо¿Àú³ÌÖУ¬£¬£¬£¬£¬£¬£¬£¬Ð¡×é³ÉÔ±³Â·ÉÌá³ö£º“·â¿Ú²»ÑŹ۵ÄÖ÷ÒªÔµ¹ÊÔ­ÓÉÊÇ·â¿Úʱƿ×ÓÊÜÈȲ»Ôȳƣ¬£¬£¬£¬£¬£¬£¬£¬ÈÃÆ¿×ÓÊÜÈÈÔȳƲÅÊÇÎÒÃǹ¥¹ØµÄÖØÖÐÖ®ÖØ¡£¡£¡£¡£¡£¡£¡£”³Â·ÉÒÔΪ£¬£¬£¬£¬£¬£¬£¬£¬¿ÉÒÔÈÃÈÈ·â°åÓë´«Ë͹ìµÀ³ÉÒ»¶¨¼Ð½Ç£¬£¬£¬£¬£¬£¬£¬£¬ÕâÑù¾Í¿ÉÒÔ°ü¹ÜÊÜÈÈÔȳÆ¡£¡£¡£¡£¡£¡£¡£µ±QCС×éÔÞ³ÉÆ¾Ö¤Õâ¸ö¼Æ»®¾ÙÐм¼¸Äºó£¬£¬£¬£¬£¬£¬£¬£¬³Â·É×Ô¸æÓÂÃÍÀ´¾ÙÐм¼¸Ä£¬£¬£¬£¬£¬£¬£¬£¬ÉõÖÁÌåÏÖ“·¹¿ÉÒÔ²»³Ô£¬£¬£¬£¬£¬£¬£¬£¬¾õÒ²¿ÉÒÔ²»Ë¯”¡£¡£¡£¡£¡£¡£¡£Ê±´úÇ¡·ê³Â·ÉµÄ±¦±¦³öÉú£¬£¬£¬£¬£¬£¬£¬£¬Ö»¹ÜÌÕ×íÔÚ×ö°Ö°ÖµÄϲÔõ±ÖУ¬£¬£¬£¬£¬£¬£¬£¬³Â·ÉÈÔ½«ÊÂÇé·ÅÔÚµÚһ룬£¬£¬£¬£¬£¬£¬£¬ÓëͬÊÂÒ»Æð¼Ó°à£¬£¬£¬£¬£¬£¬£¬£¬¼á¾ö²»ÍÏÊÖÒÕС×éºóÍÈ¡£¡£¡£¡£¡£¡£¡£

    ¹¦·ò²»¸ºÓÐÐÄÈË¡£¡£¡£¡£¡£¡£¡£µ±ËùÓм¼¸ÄÍê³Éºó£¬£¬£¬£¬£¬£¬£¬£¬·â¿Ú²»ÑŹ۵ÄÎÊÌâ»ñµÃÁ˳¹µ×½â¾ö¡£¡£¡£¡£¡£¡£¡£ÔÚ½ÓÏÂÀ´µÄÌìÏÂÒ½Ò©ÐÐÒµQCС×éЧ¹û½ÒÏþ½»Á÷»áÖУ¬£¬£¬£¬£¬£¬£¬£¬¹ÌÌåÖÆ¼ÁQCС×铽µµÍ°ÙÀÖÃß½ºÄÒÂÁ²­·â¿Ú»ú·â¿ÚȱÏÝÂÊ”µÄЧ¹û»ñµÃÁËÓë»áÆÀίµÄÒ»ÖÂÈÏͬ£¬£¬£¬£¬£¬£¬£¬£¬ÎªÑï×Ó½­Ò©Òµ¼¯ÍÅ´ø»ØÁËÒ»µÈ½±µÄÉùÓþÖ¤Êé¡£¡£¡£¡£¡£¡£¡£

http://epaper.cnpharm.com/zgyyb/html/2017-03/24/content_564505.htm?div=-1